Loading...
Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 2CL Protease
Damalanka, Vishnu C. Kim, Yunjeong Alliston, Kevin R. Weerawarna, Pathum M. Kankanamalage, Anushka C. Galasiti Lushington, Gerald H. Mehzabeen, Nurjahan Battaile, Kevin P. Lovell, Scott Chang, Kyeong-Ok
Damalanka, Vishnu C.
Kim, Yunjeong
Alliston, Kevin R.
Weerawarna, Pathum M.
Kankanamalage, Anushka C. Galasiti
Lushington, Gerald H.
Mehzabeen, Nurjahan
Battaile, Kevin P.
Lovell, Scott
Chang, Kyeong-Ok
Citations
Altmetric:
Abstract
Human noroviruses are the primary causative agents of acute gastroenteritis and a pressing public health burden worldwide. There are currently no vaccines or small molecule therapeutics available for the treatment or prophylaxis of norovirus infections. Norovirus 3CL protease plays a vital role in viral replication by generating structural and nonstructural proteins via the cleavage of the viral polyprotein. Thus, molecules that inhibit the viral protease may have potential therapeutic value. We describe herein the structure-based design, synthesis, and in vitro and cell-based evaluation of the first class of oxadiazole-based, permeable macrocyclic inhibitors of norovirus 3CL protease.
Description
Date
2016-03-10
Journal Title
Journal ISSN
Volume Title
Publisher
American Chemical Society
Collections
Files
Loading...
Mehzabeen_2016.pdf
Adobe PDF, 1.56 MB
Research Projects
Organizational Units
Journal Issue
Keywords
Citation
Damalanka, V. C., Kim, Y., Alliston, K. R., Weerawarna, P. M., Galasiti Kankanamalage, A. C., Lushington, G. H., … Groutas, W. C. (2016). Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease. Journal of Medicinal Chemistry, 59(5), 1899–1913. http://doi.org/10.1021/acs.jmedchem.5b01464